CSO Pharmitalia

Who owns CSO Pharmitalia?

CSO Pharmitalia is currently owned by Star Capital SGR through Star III Private Equity Fund (2012 vintage), since 2016.

Hand-verified · updated 2026-07-21

About CSO Pharmitalia

CSO Pharmitalia is an Italian contract sales organization (CSO) that provides outsourced commercial, sales and marketing services to pharmaceutical and life-science companies operating in Italy. Its offering spans field sales representatives (ISF), pharmacy sales agents, nutritionist biologists, market access and key account managers, medical science liaisons and remote or phone detailing, delivered across healthcare professional, payer, pharmacy and patient channels. The company works across major therapeutic areas including oncology, nephrology, orphan drugs, nutrition and general and specialist medicine, and is a member of Farmindustria, the Italian pharmaceutical industry association. It positions itself as one of the leading Italian CSOs and, per its own disclosures, employs a team of more than 200 people, with operations centred on Milan and Segrate and a legal base historically in Pisa.

Ownership journey

CSO Pharmitalia was founded in Italy in 2006 by executives drawn from multinational pharmaceutical companies, initially built around co-promotion and outsourced sales forces before broadening into specialty and hospital services, and it joined the Healthcase network in 2011. In October 2016 Star Capital, investing through its Star III Private Equity Fund, acquired a controlling stake of about 82.7 percent, taking majority control of the business. Under that ownership the company pursued a buy-and-build agenda, acquiring the digital pharma communication and e-learning specialist Educom in 2018 to add omnichannel capabilities. Star Capital remained the reference shareholder through the following years, overseeing the April 2023 disposal of Educom to a third party. No exit of CSO Pharmitalia itself has been publicly detailed, and the provided ownership facts record the Star III holding as still active.

Under PE ownership

Since the 2016 investment, Star Capital backed CSO Pharmitalia's shift from a co-promotion CSO into a broader integrated commercial partner for the life-science industry. The 2018 combination with Educom was framed as creating an Italian one-stop-shop for strategic, commercial and communication services, supporting an omnichannel go-to-market model. The company deepened its presence in higher-value therapeutic areas such as oncology, nephrology and orphan drugs, and consolidated its operations with a new central office opened in Segrate in 2020. In April 2023 it refocused the platform by selling Educom, retaining its core outsourced sales and marketing business. Across the period the group has continued to field a workforce of more than 200 staff serving pharmaceutical clients across multiple channels.